胎儿医学基金会竞争风险模型对西班牙人群孕中期预测小于胎龄儿的外部验证
单中心前瞻性队列研究纳入25484例单胎妊娠孕妇,在孕19+0至23+6周进行常规超声检查,验证胎儿医学基金会(FMF)竞争风险模型对小于胎龄儿(SGA)的预测效能。在10%假阳性率下,模型对<32周分娩的SGA<10th百分位检出率为69.6%,对<37周和≥37周分娩的检出率分别为38.7%和31.7%。模型校准良好,在该西班牙人群中表现良好。
要点
- 在10%假阳性率下,模型对<32周分娩的SGA<10th检出率为69.6%,对<37周和≥37周分别为38.7%和31.7%。
- 对SGA<3rd百分位,<32周、<37周和≥37周分娩的检出率分别为75.7%、48.2%和38.1%。
- 验证队列检出率与FMF研究中<32周分娩SGA相似,但<37周和≥37周分娩SGA较低。
核心结论
- FMF新开发的孕中期预测SGA的竞争风险模型在大型独立西班牙人群中表现良好。
研究设计与样本
- 单中心前瞻性队列研究,纳入25484例单胎妊娠孕妇,于孕19+0至23+6周行常规超声检查。
主要发现
- 在10%假阳性率下,孕妇因素、EFW和UtA-PI对SGA<10th百分位且<32周分娩的检出率分别为69.6%、38.7%和31.7%。
- 对SGA<3rd百分位且<32周、<37周和≥37周分娩,对应检出率分别为75.7%、48.2%和38.1%。
- 验证队列检出率与FMF研究中SGA<32周分娩相似,但SGA<37周和≥37周分娩较低。
- 验证队列预测效能与FMF队列中未产和白人女性亚组相似。
- 在15%假阳性率下,SGA<10th百分位且<32周、<37周和≥37周分娩的检出率分别为77.4%、50.0%和41.5%,与FMF研究10%假阳性率下相应值相似。
局限性
- 验证队列组成与开发模型的FMF队列显著不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the external validity of the new Fetal Medicine Foundation (FMF) competing-risks model for prediction in midgestation of small-for-gestational-age (SGA) neonates. METHODS: This was a single-center prospective cohort study of 25 484 women with a singleton pregnancy undergoing routine ultrasound examination at 19 + 0 to 23 + 6 weeks' gestation. The FMF competing-risks model for the prediction of SGA combining maternal factors and midgestation estimated fetal weight by ultrasound scan (EFW) and uterine artery pulsatility index (UtA-PI) was used to calculate risks for different cut-offs of birth-weight percentile and gestational age at delivery. The predictive performance was evaluated in terms of discrimination and calibration. RESULTS: The validation cohort was significantly different in composition compared with the FMF cohort in which the model was developed. In the validation cohort, at a 10% false-positive rate (FPR), maternal factors, EFW and UtA-PI yielded detection rates of 69.6%, 38.7% and 31.7% for SGA < 10th percentile with delivery at < 32, < 37 and ≥ 37 weeks' gestation, respectively. The respective values for SGA < 3rd percentile were 75.7%, 48.2% and 38.1%. Detection rates in the validation cohort were similar to those reported in the FMF study for SGA with delivery at < 32 weeks but lower for SGA with delivery at < 37 and ≥ 37 weeks. Predictive performance in the validation cohort was similar to that reported in a subgroup of the FMF cohort consisting of nulliparous and Caucasian women. Detection rates in the validation cohort at a 15% FPR were 77.4%, 50.0% and 41.5% for SGA < 10th percentile with delivery at < 32, < 37 and ≥ 37 weeks, respectively, which were similar to the respective values reported in the FMF study at a 10% FPR. The model had satisfactory calibration. CONCLUSION: The new competing-risks model for midgestation prediction of SGA developed by the FMF performs well in a large independent Spanish population. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Albaiges G, Papastefanou I, Rodriguez I, et al. External validation of Fetal Medicine Foundation competing-risks model for midgestation prediction of small-for-gestational-age neonates in Spanish population. Ultrasound Obstet Gynecol. 2023. PMID: 36971008. doi:10.1002/uog.26210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。